Life Sciences Overview
- Companies
-
36,572
- Deals
-
115,203
- Investors
-
36,303
- Exits
-
20,803
- Largest Deal
-
00000
- Capital Invested
-
00000
- Median Post Valuation
-
00000
Description
Companies involved in sciences dealing with living organisms and life processes, including biology, pharmaceuticals, biomedical technology and nutraceuticals. To learn more about the 50+ industries PitchBook tracks on the platform, visit our industry verticals page industry verticals page.
Using PitchBook’s advanced search capabilities and in-depth industry data, clients can search top Life Sciences startups, companies, investors, and acquirers. Track recent Life Sciences deals and IPOs, funding history and key participants in the M&A process. Discover new investment opportunities, industry trends and insights with research curated by our world-class analysts.
Preview data below is current as of March 2024
Life Sciences Companies to watch
This list of Life Sciences companies identifies Life Sciences startups and companies with high growth potential based on factors such as capital raised and number of funding rounds. Using our list of Life Sciences startups, our users can pinpoint companies that are likely fundraising based on recent activity in seed or early-stage funding rounds.
-
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00 -
Last Deal Type
Early Stage VC (Series B)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00 -
Last Deal Type
Early Stage VC (Series A1)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series B)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series B)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00 -
Last Deal Type
Later Stage VC (Series C)
Last Post Valuation
000.00
Top Life Sciences private and public companies
This list identifies Life Sciences companies with some of the highest valuations and market caps respectively.
Life Sciences private companies
| Company Name | Last Post Valuation | Last Deal Type |
|---|---|---|
| Genentech | 000.00 | Secondary Transaction - Private |
| Altos Labs | 000.00 | PE Growth/Expansion |
| Resilience | 000.00 | Debt - General |
| Global Life Sciences Solutions USA | 000.00 | Grant |
| Syneos Health | 000.00 | Buyout/LBO (Public to Private) |
Life Sciences public companies
| Company Name | Stock Price | Market Cap |
|---|---|---|
| Eli Lilly and Company (NYS: LLY) | 000.00 | $790.03B |
| AstraZeneca (LON: AZN) | 000.00 | $243.91B |
| Thermo Fisher Scientific (NYS: TMO) | 000.00 | $217.42B |
| Danaher (NYS: DHR) | 000.00 | $193.60B |
| Pfizer (Pharmaceuticals) (NYS: PFE) | 000.00 | $166.09B |
Want detailed data on 50+ industry verticals?
What you see here scratches the surface
Request a free trialTop Life Sciences investors and acquirers
This list showcases some of the most active investors and acquirers in Life Sciences.
| Investor Name | Number of Investments | Last Investment Size |
|---|---|---|
| National Science Foundation | 1,029 | 000.00 |
| Innovate UK | 796 | 000.00 |
| National Institutes of Health | 749 | 000.00 |
| SOSV | 418 | 000.00 |
| Novo Holdings | 407 | 000.00 |
Life Sciences Investments over time
This chart shows Life Sciences investment trends for different types of deals over time. Use it to understand the growth and changes of the deal landscape of the companies you are interested in.
Life Sciences Related research & analysis
Explore institutional-grade private market research from our team of analysts.
Life Sciences Market Map
Information technology
Healthcare
Business products and services (B2B)
Life Sciences Acquisitions over time
Life Sciences IPOs over time
Life Sciences Industry growth
This chart compares the median post valuation and median deal size for companies in this industry.
Life Sciences Company count breakdown by geography
